Search by Drug Name or NDC

    NDC 72789-0171-01 Lithium Carbonate 300 mg/1 Details

    Lithium Carbonate 300 mg/1

    Lithium Carbonate is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is LITHIUM CARBONATE.

    Product Information

    NDC 72789-0171
    Product ID 72789-171_0b293129-7212-ac60-e063-6294a90ae92f
    Associated GPIs 59500010100405
    GCN Sequence Number 004004
    GCN Sequence Number Description lithium carbonate TABLET ER 300 MG ORAL
    HIC3 H2M
    HIC3 Description BIPOLAR DISORDER DRUGS
    GCN 15731
    HICL Sequence Number 001669
    HICL Sequence Number Description LITHIUM CARBONATE
    Brand/Generic Generic
    Proprietary Name Lithium Carbonate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lithium Carbonate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 300
    Active Ingredient Units mg/1
    Substance Name LITHIUM CARBONATE
    Labeler Name PD-Rx Pharmaceuticals, Inc.
    Pharmaceutical Class Mood Stabilizer [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA076832
    Listing Certified Through 2024-12-31

    Package

    NDC 72789-0171-01 (72789017101)

    NDC Package Code 72789-171-01
    Billing NDC 72789017101
    Package 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72789-171-01)
    Marketing Start Date 2023-07-28
    NDC Exclude Flag N
    Pricing Information N/A